HypoPet is a spin-off company of the University of Zurich. The founders – Martin Bachmann, Thomas Kündig and Gabriela Senti – bring along 20 years of expertise in research in the field of Immunology and Allergology. The scientific team has discovered the possibility to reduce the secretion of allergens known to cause allergy and asthma in humans by a simple vaccination of the cat. The forth co-founder Patrik M. Paulus is an expert in finances. ETHZ student Maximilian Tornow supports the team.

Our main driver

Cat and dog allergies are important causes of rhinoconjunctivitis and asthma. Responsible for the allergy are proteins in the saliva which are transferred onto the fur. The HypoPet team is working on a new approach for pet allergies by vaccinating cats (Hypo Cat™) and dogs (HypoDog™) against their allergens. The concept is that vaccination will render them hypoallergenic by neutralizing the allergens the humans are allergic to, allowing more pet owners to keep their beloved cat or dog at home.